Evidence map›Paper›PMID 26604077›Full record

ArticleNeurogastroenterology and motility2016

Lack of endogenous cholecystokinin promotes cholelithogenesis in mice.

H H Wang, M Liu, P Portincasa, P Tso, D Q-H Wang

Abstract read
In one paragraph

Article in Neurogastroenterology and motility, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Obesity and Gallstones.Visceral medicine · 2021
    Review
  7. Review
  8. Review
  9. Article
  10. An update on the pathogenesis of cholesterol gallstone disease.Current opinion in gastroenterology · 2018
    Review
  11. Mouse models of gallstone disease.Current opinion in gastroenterology · 2018
    Review
  12. Review
  13. Journal of lipid research · 2017
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

H H WangDepartment of Medicine, Liver Center and Gastroenterology Division, Beth Israel Deaconess Medical Center, Harvard Medical School and Harvard Digestive Diseases Center, Boston, MA, USA.
M LiuDepartment of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
P PortincasaDepartment of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari, Italy.
P TsoDepartment of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
D Q-H WangDepartment of Medicine, Liver Center and Gastroenterology Division, Beth Israel Deaconess Medical Center, Harvard Medical School and Harvard Digestive Diseases Center, Boston, MA, USA.
Saint Louis University · USUniversity of Cincinnati Medical Center · USUniversity of Bari Aldo Moro · IT

Funding

Brain apoA-IV Mediates Estrogenic Reduction of Dietary Obesity in Female RatsR01DK092779 · NIDDK · UNIVERSITY OF CINCINNATI · PI LIU, MIN, WOODS, STEPHEN C · 2011 to 2015
$1.8M
Ginsenocide Rb1: A Novel Anti-Obesity and Anti-Hyperglycemic CompoundR01DK095440 · NIDDK · UNIVERSITY OF CINCINNATI · PI LIU, MIN, WOODS, STEPHEN C · 2012 to 2016
$1.6M
The Role of Dysfunctional CCK-1R in CholelithogenesisR01DK073917 · NIDDK · SAINT LOUIS UNIVERSITY · PI WANG, DAVID Q · 2008 to 2011
$1.4M
GPR30 and Hepatic Cholesterol HomeostasisR01DK106249 · NIDDK · SAINT LOUIS UNIVERSITY · PI WANG, DAVID Q · 2015 to 2017
$1.0M
Role of GPR30 in Hepatic Lipid MetabolismR56DK101793 · NIDDK · SAINT LOUIS UNIVERSITY · PI WANG, DAVID Q · 2014 to 2014
$189k
NIDDK NIH HHS DK101793NIDDK NIH HHS DK106249NIDDK NIH HHS DK73917NIDDK NIH HHS DK92779NIDDK NIH HHS DK95440NIDDK NIH HHS R01 DK073917NIDDK NIH HHS R01 DK092779NIDDK NIH HHS R01 DK095440NIDDK NIH HHS R01 DK106249NIDDK NIH HHS R56 DK101793
6 · The paper itself

Abstract

backgroundCeliac disease is an autoimmune enteropathy caused by a permanent intolerance to dietary gluten in genetically predisposed individuals. Cholecystokinin (CCK) release from the proximal small intestine and gallbladder emptying in response to a fatty meal are greatly reduced in celiac patients before they start the gluten-free diet, showing a genetic predisposition to gallstones.

methodsTo elucidate the complex pathophysiological mechanisms determining the biliary characteristic of celiac disease, we investigated the effect of the absence of endogenous CCK on cholesterol crystallization and gallstone formation in mice fed a lithogenic diet for 28 days. KEY

resultsFasting gallbladder volumes were increased and the response of gallbladder emptying to the high-fat diet was impaired in CCK knockout (KO) mice compared to wild-type mice. Because of the absence of CCK, small intestinal transit time was prolonged and intestinal cholesterol absorption was increased. During 28 days of feeding, elevated biliary cholesterol concentrations and gallbladder stasis promoted the growth and agglomeration of solid cholesterol crystals into microlithiasis and stones. Thus, cholesterol crystallization and gallstone formation were accelerated in CCK KO mice. In contrast, daily intraperitoneal administration of CCK-8 reduced gallstone formation in CCK KO mice even on the lithogenic diet. CONCLUSIONS & INFERENCES: The lack of endogenous CCK enhances susceptibility to gallstones by impairing gallbladder contractile function and small intestinal motility function. These findings show that celiac disease is an important risk factor for gallstone formation and the gallbladder motility function should be routinely examined by ultrasonography and gallbladder stasis should be prevented in celiac patients.

Indexed as

AnimalsBileCeliac DiseaseCholecystokininGallbladder EmptyingGallstonesGastrointestinal TransitMiceMice, Inbred C57BLMice, KnockoutReal-Time Polymerase Chain ReactionCholecystokininbile saltceliac diseasecholesterol absorptioncholesterol crystallizationgallbladder motilitylithogenic bile

Identifiers

PMID26604077
PMCPMC4760924
OpenAlexW2180253101

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.